Sources

7 Total Sources

Nature Medicine Study Identifies 2 Daraxonrasib Escape Routes in Pancreatic Cancer

Oncodaily4d ago

Pancreatic Cancer: Daraxonrasib Resistance Mechanisms Identified

The Boston Globe3d ago

Pancreatic cancer breakthrough: daraxonrasib doubles survival

thebiohealthbrief.com3d ago

Resistance to Daraxonrasib in Pancreatic Cancer | The BioHealth Brief

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer | New England Journal of Medicine

www.oncnursingnews.com/4d ago

Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer | Oncology Nursing News

Daraxonrasib in refractory PDAC: A one-eyed king in the land of the blind?: Med

Instagram4d ago

New research from Dr. Brian Wolpin of @danafarber, presented at #ASCO26, shows that a multi-selective RAS(ON) inhibitor nearly doubles survival time in people with metastatic pancreatic cancer. Dr. @shrutipatelmd breaks down this